金令牌首页 金令牌猎头 十佳职业经理人评选 最佳雇主评选 加入俱乐部 《职业经理人周刊》 会员区 薪酬调查报告 | 登录 |
职业经理人俱乐部首页
>> 医药医疗 >> 上海励奥医药咨询有限公司 >> 企业信息
企业编号:C001772H09A02 [查询]
上海励奥医药咨询有限公司 |
金令牌首页 金令牌猎头 十佳职业经理人评选 最佳雇主评选 加入俱乐部 《职业经理人周刊》 会员区 薪酬调查报告 | 登录 |
上海励奥医药咨询有限公司 |
LEO Pharma, founded in 1908, is a globally, leading pharmaceutical company within Dermatology and Critical Care. 丹麦利奥制药有限公司, 成立于1908年,是一家在皮肤科和危重疾病治疗领域处于国际领先的制药公司。 We maintain a strong focus on developing, manufacturing and marketing safe and efficacious drugs for treating psoriasis and other skin diseases as well as thromboembolic disorders. In 2008 LEO had a turnover of approx. USD 1.1 billion and a pre-tax profit of approx. USD 600 million. More than 16% of the turnover is invested in R&D. 我们的优势专注在开发、生产及上市安全和有效的药物, 用于治疗银屑病、皮肤病和凝血障碍等疾病。2008年,公司的营业收入达到约11亿美金, 税前利润约6亿美金, 其中超过营业收入的16%被用于投资新药的开发和研究。 LEO Pharma is a special company with strong values. The company is 100% owned by a foundation and is therefore completely independent. It represented in more than 100 countries and has around 3,600 employees around the world; Headquartered in Copenhagen. 利奥制药是一家具有独特价值观和坚定信念的公司。公司由一家基金会全资拥有,所以它完全独立经营。在全球100多个国家设有代表机构, 拥有3600多名员工,总部位于丹麦首都哥本哈根。 LEO Pharma China is a LEO Pharma wholly-owned company in China which involves in the development, marketing, and the sales of a number of patent protected products on the Chinese market. 上海励奥医药咨询有限公司由丹麦利奥制药有限公司全资拥有,涉及一系列专利产品在中国市场的开发、上市和销售。 With our exciting businesses, we are searching for responsible, dedicated and creative people and LEO Pharma offers you continued career growth and wishes you grow with the company. 随着在华业务的全面发展,我们正在不断寻找富有责任感,专注并且勇于创新的人,利奥制药将提供给你不断的职业发展。我们希望您能与公司共同成长! [收起简介] |
1、LEO Pharma in dialogue with Greek authorities on alternative to withdrawing products Press statement LEO Pharma is in dialogue with the Greek authorities to find an alternative solution to withdrawing the company’s pharmaceutical products from the Greek market. After more than 50 years of presence in the Greece, LEO Pharma fully understands the very difficult situation in Greece. During the past two-three months, LEO Pharma has therefore on several occasions been in dialogue with the Greek authorities with the intention of finding a mutually satisfactory solution benefiting the Greek economy, LEO Pharma and most importantly the patients. We firmly bel …… [详细信息] |